10.1016/j.nlm.2017.09.002 Summary Keywords neurosteroid, memory, anxiety, depression, schizophrenia, allopregnanolone, pregnenolone sulfate, Alzheimer's disease Citation Ratner MH, Kumaresan V and Farb DH (2019) Neurosteroid Actions in Memory and Neurologic/Neuropsychiatric Disorders
Always review the manufacturers stability recommendations
Consult the BPC-157 dosing guide for protocol details
Trial dose range: 112mg, once weekly, subcutaneous Standard escalation: 2mg +2mg every 4 weeks 12mg (~20 weeks) Pharmacokinetics: half-life ~6 days
CDC summarizes USP guidance: date an opened multi-dose vial at first puncture and discard it within 28 days unless the manufacturer states another opened-vial date. The dose count and 28-day window together require three vials for the 12-week protocol
Hu J et al